Figure 9.
(A-L) NCKAP1 in pan-cancer with drug sensitivity (Alectinib, Carboplatin, Cisplatin, Cyclophosphamide, Daunorubicin, Docetaxel, Doxorubicin, Epirubicin, Etoposide, Paclitaxel, Tamoxifen, and Zalcitabine) analysis.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.